ReviewCancers2026

Overcoming Trastuzumab-Pertuzumab Resistance and Optimizing Sequential Anti-HER2 Therapy in HER2-Positive Metastatic Breast Cancer.

Yutaka YamamotoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.